• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Department of Ophthalmology, University of Medicine, Cluj-Napoca, Romania.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1035-1037. doi: 10.1007/s00417-018-3901-4. Epub 2018 Jan 20.

DOI:10.1007/s00417-018-3901-4
PMID:29353345
Abstract
摘要

相似文献

1
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1035-1037. doi: 10.1007/s00417-018-3901-4. Epub 2018 Jan 20.
2
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment - reply to the letter to the editor.对随机接受雷珠单抗或曲安奈德治疗的糖尿病性黄斑水肿（DME）患者视网膜形态的详细分析——对致编辑信的回复
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1039-1040. doi: 10.1007/s00417-018-3902-3. Epub 2018 Jan 24.
3
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.对随机接受雷珠单抗或曲安奈德治疗的糖尿病性黄斑水肿（DME）患者的视网膜形态进行详细分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):49-58. doi: 10.1007/s00417-017-3828-1. Epub 2017 Oct 28.
4
Flare levels after intravitreal injection of ranibizumab, aflibercept, or triamcinolone acetonide for diabetic macular edema.玻璃体内注射雷珠单抗、阿柏西普或曲安奈德治疗糖尿病性黄斑水肿后的炎症水平。
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2301-2307. doi: 10.1007/s00417-018-4141-3. Epub 2018 Sep 20.
5
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.《糖尿病性黄斑水肿管理的第一议定书实用经验》
Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20.
6
Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.分析雷珠单抗或曲安奈德治疗糖尿病黄斑水肿的视网膜层厚度。
Acta Ophthalmol. 2018 Mar;96(2):e195-e200. doi: 10.1111/aos.13520. Epub 2017 Oct 24.
7
Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.糖尿病性黄斑水肿或视网膜静脉阻塞患者玻璃体内曲安奈德或贝伐单抗注射后中央黄斑厚度的早期变化。
Retina. 2011 Feb;31(2):290-7. doi: 10.1097/IAE.0b013e3181eef070.
8
RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS.雷珠单抗治疗对多种先前治疗均耐药的糖尿病性黄斑水肿
Retina. 2016 Jul;36(7):1292-7. doi: 10.1097/IAE.0000000000000876.
9
Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.雷珠单抗治疗的糖尿病性黄斑水肿患者队列1年随访时的多焦视网膜电图变化
Doc Ophthalmol. 2017 Oct;135(2):85-96. doi: 10.1007/s10633-017-9601-2. Epub 2017 Aug 4.
10
The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.雷珠单抗治疗前后糖尿病性黄斑水肿患者的黄斑功能与结构
Doc Ophthalmol. 2016 Apr;132(2):111-22. doi: 10.1007/s10633-016-9531-4. Epub 2016 Mar 21.

引用本文的文献

1
Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population.马来西亚人群糖尿病性黄斑水肿管理专家小组指南。
Int J Ophthalmol. 2023 May 18;16(5):712-720. doi: 10.18240/ijo.2023.05.07. eCollection 2023.
2
Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。 （原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）
Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.
3
Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.

本文引用的文献

1
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.对随机接受雷珠单抗或曲安奈德治疗的糖尿病性黄斑水肿（DME）患者的视网膜形态进行详细分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):49-58. doi: 10.1007/s00417-017-3828-1. Epub 2017 Oct 28.
2
Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness.致编辑的信：阿柏西普用于先前接受过雷珠单抗和/或贝伐单抗治疗的眼睛的糖尿病性黄斑水肿可能会进一步改善黄斑厚度。
Ophthalmic Surg Lasers Imaging Retina. 2017 Jul 1;48(7):528-529. doi: 10.3928/23258160-20170630-01.
3
在糖尿病性黄斑水肿的实际治疗中，按结局分层的脉络膜厚度变化。
Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):241-242. doi: 10.1007/s00417-018-4126-2. Epub 2018 Sep 5.
Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
将治疗方案从贝伐单抗转换为阿柏西普以治疗持续性糖尿病性黄斑水肿。
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1451-1452. doi: 10.1007/s00417-017-3669-y. Epub 2017 Apr 7.
4
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.在英国国家医疗服务体系中，雷珠单抗治疗糖尿病性黄斑水肿的真实世界疗效
Am J Ophthalmol. 2017 Feb;174:175-176. doi: 10.1016/j.ajo.2016.10.013. Epub 2016 Nov 25.
5
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.阿柏西普治疗糖尿病性黄斑水肿：评估其作为一线和二线治疗选择的疗效
Eye (Lond). 2017 Feb;31(2):342. doi: 10.1038/eye.2016.238. Epub 2016 Nov 4.
6
Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.致：玻璃体内注射地塞米松植入物治疗糖尿病性黄斑水肿的长期疗效和安全性的评论
Eur J Ophthalmol. 2016 Nov 4;26(6):e171-e172. doi: 10.5301/ejo.5000869.
7
Pro-permeability Factors in Diabetic Macular Edema; The Diabetic Macular Edema Treated With Ozurdex Trial.糖尿病性黄斑水肿中的促通透性因子；Ozurdex治疗糖尿病性黄斑水肿试验
Am J Ophthalmol. 2016 Oct;170:244-245. doi: 10.1016/j.ajo.2016.06.048. Epub 2016 Aug 18.
8
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.既往抗血管内皮生长因子治疗持续性糖尿病黄斑水肿后改用阿柏西普治疗
Am J Ophthalmol. 2016 Aug;168:290-291. doi: 10.1016/j.ajo.2016.05.015. Epub 2016 Jun 4.
9
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.视网膜疾病中抗血管内皮生长因子（VEGF）药物的治疗与延长方案：文献综述与共识建议
Retina. 2015 Aug;35(8):1489-506. doi: 10.1097/IAE.0000000000000627.
10
Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).高清光谱域光学相干断层扫描（Spectralis）测量黄斑厚度的正常参考值。
Am J Ophthalmol. 2009 Aug;148(2):266-71. doi: 10.1016/j.ajo.2009.03.006. Epub 2009 May 9.